Clinical trial Recruiting at 3 sites Interventional Ages 18 to 85

Digital solutions for early treatment of cognitive disabilities in chronic neurological diseases

Official title: EARLY-COGN^3 - Smart Digital Solutions for EARLY Treatment of COGnitive Disability: a Neuropsychological, Neurophysiological and Neurobiological Perspective in Chronic Neurological Diseases - PNRR-MCNT2-2023-12377069

Run by IRCCS Centro San Giovanni di Dio Fatebenefratelli · NCT06657274 · Data updated 2026-11-12

This study is testing a digital brain training program to see if it helps people with Mild Cognitive Impairment, subjective cognitive complaints, or Parkinson's Disease improve their thinking skills compared to a different type of brain activity.

More Parkinson Disease trials

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment60 (estimated)
SponsorIRCCS Centro San Giovanni di Dio Fatebenefratelli
Academic / other
Locations3 sites (Brescia, IT and 2 other locations)
StatusRecruiting
StartedDecember 9, 2024
Main results expectedAugust 30, 2026
Study endsAugust 30, 2026
Registry record updatedMay 2, 2025
Trial IDNCT06657274 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 18 to 85 with a diagnosis of MCI, SCCs, or PD who meet specific cognitive assessment criteria.

Probably not a fit

Patients with significant psychiatric or medical conditions that could interfere with assessments or those currently undergoing rehabilitation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of a digital cognitive rehabilitation program for patients with Mild Cognitive Impairment (MCI), Subjective Cognitive Complaints (SCCs), and Parkinson's Disease (PD). A total of 60 participants will be recruited and divided into two groups: one receiving home-based cognitive telerehabilitation and the other receiving unstructured cognitive stimulation. Participants will undergo a series of assessments by neuropsychologists and will also have blood samples taken and Transcranial Magnetic Stimulation (TMS) applied at the beginning and end of the treatment. The study will assess cognitive improvements over a 5-week period and at a 3-month follow-up.

Why it matters

Potential benefit: If successful, this approach could enhance cognitive function and quality of life for patients with early-stage cognitive impairments.

How similar studies have gone: Previous studies have shown promise in using digital cognitive interventions for similar conditions, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of PD (Hoehn \& Yahr\<3); MCI (with CDR scale≤0.5, MMSE ≥24), and SCC (Subjective Cognitive Complaints);
* Montreal Cognitive Assessment (MoCA) corrected score ≥17.36
* Education ≥ 5 years
* Age eligible for the study: 18≤age≤85
* Native Italian speakers
* Absence of marked hearing/visual impairment
* All of the subjects will have normal or corrected-to-normal vision.
* Agreement to participate by signing the informed consent form
* Availability of a caregiver/study partner able to support the participant
* No rehabilitation program in place at the time of enrolment or in the last 3 months before enrolment
* Stable drug treatment (last 3 months), if any

Exclusion Criteria:

* Presence of any medical or psychiatric illness that could interfere with completing assessments;
* Presence of any medical condition representing a contraindication to TMS.

Where it's running

  • IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli
    Brescia, It, Italy
    Recruiting
  • IRCCS Centro Neurolesi Bonino Pulejo
    Messina, It, Italy
    Recruiting
  • Fondazione Don Carlo Gnocchi - ONLUS, Milan
    Milan, It, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.